Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Passage Bio Inc
(NQ:
PASG
)
0.6620
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,221
Open
0.6620
Bid (Size)
0.6505 (20)
Ask (Size)
0.7300 (4)
Prev. Close
0.6620
Today's Range
0.6620 - 0.6620
52wk Range
0.5751 - 1.790
Shares Outstanding
61,767,286
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 30, 2024
From
Passage Bio
Via
GlobeNewswire
Performance
YTD
-26.53%
-26.53%
1 Month
-22.12%
-22.12%
3 Month
-46.61%
-46.61%
6 Month
-60.60%
-60.60%
1 Year
-16.59%
-16.59%
More News
Read More
PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
August 08, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
August 06, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
August 01, 2024
From
Passage Bio
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 16, 2024
Via
InvestorPlace
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
July 16, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 14, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 22, 2024
From
Passage Bio
Via
GlobeNewswire
PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023
March 06, 2024
Via
InvestorPlace
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
March 04, 2024
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
February 27, 2024
From
Passage Bio
Via
GlobeNewswire
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
February 01, 2024
Via
InvestorPlace
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
December 25, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
December 21, 2023
Via
Benzinga
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities
December 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.